Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid.

The present study employed two human colon cancer cell lines, DLD-1 and Colo 320DM, to investigate whether the provitamin A activity of carotenoids is necessary for their antitumor effect on colon cancer. Carotenoids, including alpha- and beta-carotene and canthaxanthin, significantly suppressed cell viability [measured by tetrazolium (MTT) assay], DNA synthesis (measured by [3H]thymidine uptake), and cell proliferation (measured by cell counting) and thus showed growth-inhibitory effects on both cancer cell lines. Because canthaxanthin does not have provitamin A activity, these results suggest that the carotenoid directly inhibited the cell growth. Moreover, the effective dose of retinoic acid, an active metabolite of vitamin A, was much higher than that of alpha- or beta-carotene. A retinoic acid-inducible gene, retinoic acid receptor-beta, was not enhanced in either type of cancer cell by treatment with alpha- or beta-carotene. Therefore, like canthaxanthin, alpha- and beta-carotene might also exert their tumor-suppressing effects without being converted to retinoids. These results suggest that a certain antitumor activity of carotenoids may not necessarily require their provitamin A activity.

[1]  H. Mori,et al.  Synergistic suppression of azoxymethane-induced foci of colonic aberrant crypts by the combination of beta-carotene and perilla oil in rats. , 1996, Carcinogenesis.

[2]  S. Kojima,et al.  Suppression of mouse skin papilloma by canthaxanthin and beta-carotene in vivo: possibility of the regression of tumorigenesis by carotenoids without conversion to retinoic acid. , 1996, Nutrition and cancer.

[3]  T. Noda,et al.  Growth retardation in human cervical dysplasia-derived cell lines by beta-carotene through down-regulation of epidermal growth factor receptor. , 1995, The American journal of clinical nutrition.

[4]  N. Shivapurkar,et al.  Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and beta-carotene in rats on a high-risk diet. , 1995, Cancer letters.

[5]  N. Shivapurkar,et al.  Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. , 1995, Carcinogenesis.

[6]  W. Blaner,et al.  Regulation of adipocyte gene expression by retinoic acid and hormones: effects on the gene encoding cellular retinol-binding protein. , 1995, Journal of lipid research.

[7]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[8]  G. Scita,et al.  Uptake and cleavage of beta-carotene by cultures of rat small intestinal cells and human lung fibroblasts. , 1992, Methods in enzymology.

[9]  J. Olson,et al.  Vitamin A and carotenoids as antioxidants in a physiological context. , 1993, Journal of nutritional science and vitaminology.

[10]  M. Murakoshi,et al.  Potent Preventive Action of α-Carotene against Carcinogenesis: Spontaneous Liver Carcinogenesis and Promoting Stage of Lung and Skin Carcinogenesis in Mice Are Suppressed More Effectively by α-Carotene Than by β-Carotene , 1992 .

[11]  S. Das,et al.  beta-Carotene-mediated inhibition of a DNA adduct induced by 7,12-dimethylbenz(a)anthracene and 7-hydroxymethyl-12-methylbenz(a)anthracene in mouse mammary gland in vitro. , 1992, European journal of cancer.

[12]  X. D. Wang,et al.  Retinoic acid can be produced from excentric cleavage of beta-carotene in human intestinal mucosa. , 1992, Archives of biochemistry and biophysics.

[13]  J. Bertram,et al.  Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. , 1991, Carcinogenesis.

[14]  N. Krinsky.  Effects of carotenoids in cellular and animal systems. , 1991, The American journal of clinical nutrition.

[15]  R. Evans,et al.  Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Prasad,et al.  Beta-carotene induces morphological differentiation and decreases adenylate cyclase activity in melanoma cells in culture. , 1990, Journal of the American College of Nutrition.

[17]  L. Gerber,et al.  Carotenoid cleavage: alternative pathways. , 1990, Methods in enzymology.

[18]  R. Ziegler,et al.  A review of epidemiologic evidence that carotenoids reduce the risk of cancer. , 1989, The Journal of nutrition.

[19]  N. Temple,et al.  Protective Effect of β-Carotene Against Colon Tumors in Mice , 1987 .

[20]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[21]  B. S. Alam,et al.  The effect of different levels of dietary beta-carotene on DMBA-induced salivary gland tumors. , 1987, Nutrition and cancer.

[22]  H. Moriwaki,et al.  Antitumor activity of vitamin A and its derivatives. , 1984, Journal of the National Cancer Institute.

[23]  K. Ingold,et al.  beta-Carotene: an unusual type of lipid antioxidant. , 1984, Science.

[24]  B. Underwood.  6 – Vitamin A in Animal and Human Nutrition , 1984 .

[25]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[26]  N. Krinsky.  Photobiology of Carotenoid Protection , 1982 .